ClinicalTrials.Veeva

Menu

Mortality Reductions Based on AUD/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk

NYU Langone Health logo

NYU Langone Health

Status

Active, not recruiting

Conditions

HIV Risk
Substance Use Disorders
Alcohol Use Disorder
Cardiovascular Disease

Treatments

Behavioral: Navigation, compensation, and personalization

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05828849
22-01584

Details and patient eligibility

About

The purpose of this research study is to investigate if a personalized intervention including parts such as navigation (focus on patient outreach efforts, missed and completed encounters), personalization (individual health benefits) and compensation (value health-related costs borne by patients) will help people reduce their chances of dying from preventable causes, including heart attacks, strokes, drinking alcohol, substance abuse, HIV, and other conditions.

Enrollment

87 patients

Sex

All

Ages

35 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age 35 to 64

  2. Low SES (≤ $38,000 annual income, based on 2019 20th percentile NYC income, adjusted for family size)

  3. Expected mortality ≥1% per year (based on age, sex, race/ethnicity), with ≥1 of the following contributors:

    1. 10-year cardiovascular risk ≥10% (assessed by ASCVD risk tool)
    2. Heavy alcohol consumption (defined using SAMHSA binge drinking definition, drinking >4 standard drinks for men and >3 standard drinks for women on same occasion in past month)
  4. Willing to be navigated to Health and Hospitals Corporation of New York health system.

  5. Ability to provide written informed consent in English or Spanish

Exclusion criteria

  1. Receives regular care elsewhere than Health and Hospitals Corporation of New York
  2. Already diagnosed with high mortality-condition(s) that are not included in the simulation model.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

87 participants in 2 patient groups

Low SES Population - Intervention
Experimental group
Description:
Participants receive the study intervention, composed of navigation, compensation, and personalization for study participants. The intervention will be administered in person to the participants recruited for the study and will be administered by peer navigators who will be trained on Motivational Interviewing (MINT) techniques.
Treatment:
Behavioral: Navigation, compensation, and personalization
Low SES Population - No Intervention
No Intervention group
Description:
Participants receive no intervention components of navigation, compensation, and personalization. Participants will receive their normal medical care through regular doctor visits without any intervention or personalization.

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Jonathan Feelemyer; Ronald S Braithwaite, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems